Connie Montgomery: Every Patient Deserves Representation in Clinical Research
Connie Montgomery, National Member Board of Trustees Camden Coalition at Camden Coalition, shared American Society of Hematology‘s a post on LinkedIn:
“Trialport supports that all people need to be represented in clinical trials especially for those of us living with bleeding disorders and other diseases.”
American Society of Hematology shared a post on LinkedIn:
“Representation in clinical trials doesn’t improve by accident—it improves by design.
The ASH Toolkit for Clinical Trial Sponsors provides a step-by-step, practical resource to build equity into the trial life cycle from the outset.
Find concrete recommendations, examples, and curated references to help enhance access, broaden participation, and generate results that truly reflect the patients impacted by the disease or therapy.
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
-
Sep 24, 2026, 06:08Christopher Salerno: AI-Powered At-Home Anemia Screening Advances Telehealth Access
-
Sep 24, 2026, 05:38Aya Qattan: When a Normal CBC Does Not Mean Normal Iron Status
-
Sep 24, 2026, 05:11Mastering Warm Autoimmune Hemolytic Anemia Diagnosis and Practice – ASH Education
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation